FIELD: medicine.
SUBSTANCE: group of inventions refers to an oral composition for treating cancer containing a metal associated with at least one tumor antigen and at least one alloantigen or fragments thereof, wherein said metal is magnesium, calcium or strontium or a combination thereof, and wherein said alloantigen is selected from albumin, serums mixed from peripheral blood of healthy individuals, or serums mixed from peripheral blood of the patients with diagnosed cancer. Group of inventions also relates to a method of treating cancer in a subject in need thereof, comprising orally administering to a subject a therapeutically effective dose of said composition; a method for inducing an anti-inflammatory immune reaction in an individual comprising oral administration of a therapeutically effective dose of the composition to a subject, wherein the composition contains a tumor antigen and an alloantigen bound to a metal.
EFFECT: group of inventions provides treating cancer and inducing an anti-inflammatory immune reaction in a subject.
31 cl, 2 dwg, 4 tbl, 13 ex
Title |
Year |
Author |
Number |
CDH3-PEPTIDE AND DRUG PREPARATION CONTAINING IT |
2008 |
- Nisimura Jasukharu
- Imai Katsunori
- Tsunoda Takuja
- Nakamura Jusuke
|
RU2483078C2 |
T-CELLS WITH TRANSDUCED ANTIGEN APPLIED AS ANTIGEN DELIVERY SYSTEMS |
2003 |
- Traversari Katja
- Bordin'On Klaudio
|
RU2330884C2 |
METHODS AND COMPOSITIONS FOR TREATING TUMORS |
2017 |
- Griscelli Frank
- Turhan Ali
- Bennaceur-Griscelli Annelise
|
RU2741786C2 |
COMBINATION OF RECOMBINANT MICROBACTERIUM AND BIOLOGICALLY ACTIVE AGENT AS VACCINE |
2005 |
- Lejfer Al'Brekht
- Ajzele Bernd
- Grode Leander
|
RU2495677C2 |
COMBINATION OF AN IMMUNE CHECKPOINT MODULATOR AND A COMPLEX CONTAINING A CELL-PENETRATING PEPTIDE, A CARGO MOLECULE, AND A TLR PEPTIDE AGONIST, FOR APPLICATION IN MEDICINE |
2017 |
- Derouazi Madiha
- Belnoue Elodie
|
RU2769314C1 |
METHODS OF TREATING CANCER USING ACTIVATED T-CELLS |
2016 |
- Tang, Longqing
- Tao, Ran
- Liu, Junyun
- Wu, Dongyun
- Han, Yanyan
- Li, Jin
- Zhou, Xiangjun
|
RU2729362C2 |
MYBL2 EPITOPE PEPTIDES AND VACCINES CONTAINING THEM |
2009 |
- Tsunoda Takuja
- Okhsava Rjudzi
|
RU2496787C2 |
METHODS FOR INCREASING EFFECTIVENESS OF ANTITUMOUR IMMUNE RESPONSE |
2015 |
|
RU2689162C2 |
IMMUNOGENIC PEPTIDES FOR APPLICATION FOR PREVENTION AND/OR TREATMENT OF INFECTIOUS DISEASES, AUTOIMMUNE DISEASES, THE IMMUNE RESPONSES TO ALLOGENEIC FACTORS, ALLERGIC DISEASES, TUMOUR, TRANSPLANT REJECTION AND IMMUNE RESPONSES AGAINST VIRAL VECTORS USED FOR GENETIC THERAPY OR GENETIC VACCINATION |
2011 |
|
RU2615460C2 |
CDCA1 EPITOPE PEPTIDES AND VACCINES CONTAINING SAME |
2009 |
- Tsunoda Takuja
- Okhsava Rjudzi
- Josimura Satiko
|
RU2502740C2 |